Isolated limb infusion with fotemustine after dacarbazine chemosensitisation for inoperable loco-regional melanoma recurrence

European Journal of Surgical Oncology

Volumn 30, Issue 10, 2004, Pages 1107-1112

  Bonenkamp, J J ^a   Thompson, J F ^a,b   de Wilt, J H ^a   Doubrovsky, A ^a   de Faria Lima, R ^a   Kam, P C A ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Dacarbazine; Extremities; Fotemustine; Isolated limb infusion; Melanoma

Indexed keywords

DACARBAZINE; DACTINOMYCIN; DEXAMETHASONE; FOTEMUSTINE; MELPHALAN; TROPISETRON; ALKYLATING AGENT; ANTINEOPLASTIC AGENT; NITROSOUREA DERIVATIVE; ORGANOPHOSPHORUS COMPOUND;

ADVANCED CANCER; AMPUTATION; ARTICLE; CANCER REGRESSION; CANCER STAGING; CHEMOSENSITIVITY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; DRUG TISSUE LEVEL; HUMAN; LIMB DISEASE; MELANOMA; NEUTROPENIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THROMBOCYTOPENIA; TREATMENT FAILURE; AGED; FOLLOW UP; INSTRUMENTATION; LEG; LIMB SALVAGE; METHODOLOGY; MIDDLE AGED; REGIONAL PERFUSION; REMISSION; SALVAGE THERAPY; SKIN TUMOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; AGED, 80 AND OVER; AMPUTATION; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; DACARBAZINE; FOLLOW-UP STUDIES; HUMANS; LIMB SALVAGE; LOWER EXTREMITY; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NITROSOUREA COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; REMISSION INDUCTION; SALVAGE THERAPY; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 13944274257     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2004.07.028     Document Type: Article

References (23)

1. B.C. Vrouenraets O.E. Nieweg B.B.R. Kroon Thirty-five years of isolated limb perfusion for melanoma: Indications and results Br J Surg 83 1996 1319-1328
2. J.F. Thompson P.C. Kam R.C. Waugh C.R. Harman Isolated limb infusion with cytotoxic agents: A simple alternative to isolated limb perfusion Semin Surg Oncol 14 1998 238-247
3. P. Lindner J.F. Thompson J.H.W. de Wilt M. Colman P.C.A. Kam Double isolated limb infusion with cytotoxic agents for recurrent melanoma Ann Surg Oncol 2004 In Press
4. J.F. Thompson M.P. Gianoutsos Isolated limb perfusion for melanoma: effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs World J Surg 16 1992 227-233
5. C.R. Rossi M. Foletto P. Pilati S. Mocellin M. Lise Isolated limb perfusion in locally advanced cutaneous melanoma Semin Oncol 29 2002 400-409
6. E. Bajetta M. Del Vecchio C. Bernard-Marty et al. Metastatic melanoma: chemotherapy Semin Oncol 29 2002 427-445
7. C. Jacquillat D. Khayat P. Banzet et al. Final report of the French multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases Cancer 66 1990 1873-1878
8. S. Aamdal B. Gerard T. Bohman M. D'Incalci Sequential administration of dacarbazine and fotemustine in patients with disseminated malignant melanoma - an effective combination with unexpected toxicity Eur J Cancer 28 1992 447-450
9. M.T. Hayes J. Bartley P.G. Parsons In vitro evaluation of fotemustine as a potential agent for limb perfusion in melanoma Melanoma Res 8 1998 67-75
10. L. Pontes M. Lopes M. Ribeiro J.G. Santos M.C. Azevedo Isolated limb perfusion with fotemustine after chemosensitization with dacarbazine in melanoma Melanoma Res 7 1997 417-419
11. J. Wieberdink C. Benckhuysen R.P. Braat E.A. van Slooten G.A. Olthuis Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions Eur J Cancer Clin Oncol 18 1982 905-910
12. C.M. Balch A.C. Buzaid M.B. Atkins et al. A new American Joint Committee on Cancer staging system for cutaneous melanoma Cancer 88 2000 1484-1491
13. C.M. Balch A.C. Buzaid S.J. Soong et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma J Clin Oncol 19 2001 3635-3648
14. J.F. Thompson J.A. Hunt K.F. Shannon P.C. Kam Frequency and duration of remission after isolated limb perfusion for melanoma Arch Surg 132 1997 903-907
15. D. Lienard F.J. Lejeune P. Ewalenko In transit metastases of malignant melanoma treated by high dose rTNF alpha in combination with interferon-gamma and melphalan in isolation perfusion World J Surg 16 1992 234-240
16. K.U. Schallreuter E. Wenzel F.W. Brassow J. Berger E.W. Breitbart W. Teichmann Positive phase II study in the treatment of advanced malignant melanoma with fotemustine Cancer Chemother Pharmacol 29 1991 85-87
17. S.L. Gerson J.K. Willson O6-alkylguanine-DNA alkyltransferase. A target for the modulation of drug resistance Hematol Oncol Clin North Am 9 1995 431-450
18. S.M. Lee G.P. Margison A.A. Woodcock N. Thatcher Sequential administration of varying doses of dacarbazine and fotemustine in advanced malignant melanoma Br J Cancer 67 1993 1356-1360
19. M. Christmann M. Pick H. Lage D. Schadendorf B. Kaina Acquired resistance of melanoma cells to the antineoplastic agent fotemustine is caused by reactivation of the DNA repair gene MGMT Int J Cancer 92 2001 123-129
20. D.L. Bartlett G. Ma H.R. Alexander S.K. Libutti D.L. Fraker Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics Cancer 80 1997 2084-2090
21. A.M. Eggermont A.N. van Geel J.H. de Wilt T.L. ten Hagen The role of isolated limb perfusion for melanoma confined to the extremities Surg Clin North Am 83 2003 371-384
22. J.H. De Wilt J.F. Thompson Is there a role for isolated limb perfusion with tumor necrosis factor in patients with melanoma? Ann Surg Oncol 11 2004 119-121
23. C.R. Rossi F.J. Lejeune L. Pontes et al. Phase I-II study on isolation antiblastic fotemustine perfusion after dacarbazine chemosensitization for advanced melanoma of the extremities Melanoma Res 13 2003 293-297